MATER DEI (MATD3) Main Indicators
Basic Data - MATD3
Company | MATER DEI |
Corporate Name | HOSPITAL MATER DEI S/A |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | |
Share | MATD3 |
Quote Date | 12/02/2024 |
Share Type | ON |
Last Closing | R$ 4.05 |
Quotation Factor | 1 Share |
Financial Volume | R$ 3.39 M |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
Participation Indexes | GPTW, IBRA, ICON, IGC, IGCT, IGNM, ITAG |
Updated 12/03/2024 |
Relative Prices - MATD3
Price/Earnings | -4.42 |
Price/SBV | 0.96 |
Price/Net Sales | 0.62 |
Price/CFO | 8.07 |
Price/FCF | -33.74 |
Price/Total Assets | 0.32 |
Price/EBIT | -4.73 |
Price/Working Capital | 1.28 |
Price/NCAV | -0.77 |
EV/EBIT | -7.24 |
EV/EBITDA | -11.31 |
EV/Net Sales | 0.95 |
EV/CFO | 12.35 |
EV/FCF | -51.62 |
EV/Total Assets | 0.49 |
Company Market Cap | R$ 1.42 B |
Enterprise Value | R$ 2.17 B |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 4.05 |
Share Price Date | 12/02/2024 |
Dividend Yield | 1.85% |
Updated 12/03/2024 |
Income Statement - MATD3
Net Revenue | R$ 2.28 B |
Gross Result | R$ 704.31 M |
EBIT | - R$ 299.99 M |
Depreciation and Amortization | - R$ 108.15 M |
EBITDA | - R$ 191.84 M |
Net Profit | - R$ 320.92 M |
Net Profit/Share | - R$ 0.90 |
Updated 11/07/2024 |
Net Revenue | R$ 570.82 M |
Gross Result | R$ 173.57 M |
EBIT | R$ 153.68 M |
Depreciation and Amortization | - R$ 27.24 M |
EBITDA | R$ 180.92 M |
Net Profit | R$ 75.37 M |
Profit/Share | R$ 0.21 |
Updated 11/07/2024 |
Price and Volume Behavior - MATD3
Lowest Price 52 weeks | R$ 4.05 |
Highest Price 52 weeks | R$ 8.46 |
Variation 2024 | -48.70% |
Variation 1 year | -48.44% |
Variation 2 years(total) | -45.29% |
Variation 2 years(yearly) | -26.01% |
Variation 3 years(total) | -71.18% |
Variation 3 years(yearly) | -33.92% |
Variation 4 years(total) | - |
Variation 4 years(yearly) | - |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 2.67 M |
Updated 12/03/2024 |
Returns and Margins - MATD3
Return on Initial Tangible Capital | -7.49% |
Return on Initial Invested Capital | -7.38% |
Pre-Tax Return on Initial Tangible Capital | -11.34% |
Pre-Tax Return on Initial Invested Capital | -11.18% |
Return on Initial Shareholder´s Equity | -19.31% |
Return on Initial Asset | -6.20% |
Gross Margin | 30.89% |
Net Margin | -14.07% |
EBIT Margin | -13.16% |
EBITDA Margin | -8.41% |
Initial Asset Turnover | 0.44 |
Financial Leverage | 3.00 |
Liabilities/Net Worth | 2.00 |
Net Debt/EBITDA | -3.92 |
Updated 11/07/2024 |
Balance Sheet - MATD3
Cash and Cash Equivalents | R$ 704.45 M |
Total Assets | R$ 4.41 B |
Short-Term Debt | R$ 99.72 M |
Long-Term Debt | R$ 1.36 B |
Gross Debt | R$ 1.46 B |
Net Debt | R$ 751.68 M |
Shareholder´s Equity | R$ 1.47 B |
Share Book Value | R$ 4.12 |
Common Shares | 357,669,194 |
Preferred Shares | 0 |
Total | 357,669,194 |
Common Shares in Treasury | 5,334,935 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 5,334,935 |
Common Shares (Except Treasury) | 352,334,259 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 352,334,259 |
Updated 11/07/2024 |
Cash Flow - MATD3
Operating Cash Flow | R$ 175.71 M |
Cash Flow from Investments | R$ 179.79 M |
Financing Cash Flow | R$ 83.28 M |
Increase (Reduction) in Cash and Equivalents | R$ 438.78 M |
Updated 11/07/2024 |
Operating Cash Flow | R$ 103.30 M |
Cash Flow from Investments | R$ 353.34 M |
Financing Cash Flow | - R$ 21.57 M |
Increase (Reduction) in Cash and Equivalents | R$ 435.06 M |
Updated 11/07/2024 |
Experimental - MATD3
CAPEX 3 months | - R$ 41.22 M |
Free Cash Flow 3 months | R$ 62.08 M |
CAPEX 12 months | - R$ 217.76 M |
Free Cash Flow 12 months | - R$ 42.05 M |
Updated 11/07/2024 |